Breaking News Instant updates and real-time market news.

ANDV

Andeavor

$114.77

0.43 (0.38%)

, CVI

CVR Energy

$37.47

0.23 (0.62%)

04:55
01/03/18
01/03
04:55
01/03/18
04:55

Wolfe Research to hold a conference

2018 Oil & Gas Refiners 1:1 Conference is being held in Boston on January 2-3.

ANDV

Andeavor

$114.77

0.43 (0.38%)

CVI

CVR Energy

$37.47

0.23 (0.62%)

DK

Delek US

$35.83

0.89 (2.55%)

HFC

HollyFrontier

$51.30

0.08 (0.16%)

PAR

PAR Technology

$9.20

-0.15 (-1.60%)

PBF

PBF Energy

$36.27

0.82 (2.31%)

PSX

Phillips 66

$101.75

0.6 (0.59%)

VLO

Valero

$92.80

0.89 (0.97%)

  • 09

    Jan

  • 01

    Feb

  • 02

    Feb

ANDV Andeavor
$114.77

0.43 (0.38%)

12/06/17
WELS
12/06/17
NO CHANGE
Target $141
WELS
Outperform
Andeavor price target raised to $141 from $127 at Wells Fargo
Wells Fargo analyst Roger Read raised his price target for Andeavor to $141 and says the shares remain his top pick following the company's analyst day. Andeavor expects "meaningful" EBITDA growth across all three segments and plans to grow its dividend with the growth of the company, Read told investors earlier in a research note. He raised his estimates for the company and keeps an Outperform rating on the name.
10/17/17
WELS
10/17/17
NO CHANGE
Target $127
WELS
Outperform
Andeavor price target raised to $127 from $106 at Wells Fargo
Wells Fargo raised its price target for Andeavor to $127 from $106 saying a product-driven rally is on track. The analyst reiterates an Outperform rating on the shares.
11/02/17
EVER
11/02/17
UPGRADE
EVER
Outperform
Andeavor upgraded to Outperform from In Line at Evercore ISI
Evercore ISI analyst Doug Terreson upgraded Andeavor to Outperform with a $128 price target. Terreson expects profits in Refining, Chemicals and Midstream will strengthen during 2018-2019 and does not believe consensus estimates reflect his positive outlook.
11/03/17
JPMS
11/03/17
INITIATION
Target $121
JPMS
Overweight
Andeavor reinstated with an Overweight at JPMorgan
JPMorgan analyst Phil Gresh reinstated Andeavor with an Overweight rating and $121 price target. The rating is unchanged and the price target is raised from $107.
CVI CVR Energy
$37.47

0.23 (0.62%)

DK Delek US
$35.83

0.89 (2.55%)

12/08/17
BOFA
12/08/17
DOWNGRADE
Target $34
BOFA
Underperform
Delek US downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Doug Leggate downgraded Delek US to Underperform to reflect strong recent share outperformance and a wide WTI-Brent spread that is unsustainable. Leggate raised Delek's price target to $34 from $30.
12/21/17
HOWW
12/21/17
UPGRADE
HOWW
Focus List
Delek US upgraded to Focus List from Sector Perform at Scotia Howard Weil
Scotia Howard Weil upgraded Delek US to Focus List from Sector Perform and raised its price target to $41 from $26.
11/17/17
TUDR
11/17/17
UPGRADE
TUDR
Buy
Delek US upgraded to Buy from Hold at Tudor Pickering
11/14/17
WELS
11/14/17
UPGRADE
Target $40
WELS
Outperform
Delek US upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Roger Read upgraded Delek US Holdings to Outperform and raised his price target for the shares to $40 from $29. Following the company's Q3 results, the analyst sees "greater and quicker" synergies related to the Alon USA Energy merger and "sustainably wider" WTI-Midland differentials.
HFC HollyFrontier
$51.30

0.08 (0.16%)

12/18/17
GSCO
12/18/17
DOWNGRADE
Target $30
GSCO
Sell
Holly Energy downgraded to Sell from Neutral at Goldman Sachs
Goldman analyst Jerren Holder downgraded Holly Energy (HEP) to Sell due to premium valuation, risks related to high dependency on HollyFrontier (HFC) for growth, and limited organic growth backlog. The analyst lowered his price target on shares to $30 from $34.
12/21/17
HOWW
12/21/17
DOWNGRADE
HOWW
Outperform
HollyFrontier downgraded to Outperform from Focus List at Scotia Howard Weil
12/08/17
12/08/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. D.R. Horton (DHI) downgraded to Market Perform from Outperform at Keefe Bruyette. 2. Ball Corp. (BLL) and Silgan Holdings (SLGN) were downgraded to Underweight from Sector Weight at KeyBanc. 3. Ciena (CIEN) downgraded to Neutral from Overweight at Piper Jaffray with analyst Troy Jensen saying he sees 2018 being a more challenging year for the company. 4. Sigma Designs (SIGM) was downgraded to Hold from Buy at Lake Street, Benchmark, and Craig-Hallum. 5. HollyFrontier (HFC) downgraded to Underperform from Neutral at BofA/Merrill with analyst Doug Leggate citing full valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/08/17
BOFA
12/08/17
DOWNGRADE
Target $45
BOFA
Underperform
HollyFrontier downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Doug Leggate downgraded HollyFrontier to Underperform citing full valuation and and raised its price target to $45 from $36 to reflect a lower corporate tax rate.
PAR PAR Technology
$9.20

-0.15 (-1.60%)

PBF PBF Energy
$36.27

0.82 (2.31%)

11/28/17
GSCO
11/28/17
DOWNGRADE
Target $29
GSCO
Sell
PBF Energy downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Neil Mehta downgraded PBF Energy to Sell with the shares up 58% in the last three months. The analyst sees downside to 2018/2019 consensus expectations for both earnings and free cash flow amid less favorable crude differentials. Mehta has a six-month price target for the shares of $29, which is increased from $27.
11/28/17
SBSH
11/28/17
NO CHANGE
SBSH
Citi adds Portola, removes PBF from 'Value Creators' List
Citi analyst Scott Chronert added Portola Pharmaceuticals (PTLA) and removed PBF Energy (PBF) from his firm's "Value Creators" SMID Focus List. The analyst views Portola as a "catalyst rich Biotech with M&A potential" and notes PBF shares are up 41% since the end of August.
12/12/17
JPMS
12/12/17
DOWNGRADE
Target $31
JPMS
Underweight
PBF Energy downgraded to Underweight from Neutral at JPMorgan
JPMorgan Phil Gresh downgraded PBF Energy to Underweight with an unchanged price target of $31. The valuation looks full following the recent outperformance, Gresh tells investors in a research note. Further, the analyst believes the Q4 consensus estimates could prove to be too high, with recently degrading crack spreads.
11/14/17
LEHM
11/14/17
UPGRADE
Target $39
LEHM
Overweight
PBF Energy upgraded to Overweight from Underweight at Barclays
Barclays analyst Paul Cheng double upgraded PBF Energy to Overweight from Underweight and raised his price target for the shares to $39 from $28. The analyst believes the "golden age" of refining, driven by rising North American crude oil and natural gas production, has "years of running room."
PSX Phillips 66
$101.75

0.6 (0.59%)

10/16/17
JEFF
10/16/17
DOWNGRADE
Target $77
JEFF
Underperform
Phillips 66 downgraded to Underperform from Hold at Jefferies
Jefferies analyst Corey Goldman downgraded Phillips 66 to Underperform and raised his price target for the shares to $77 from $76. The analyst believes the stock's current "premium valuation" is unjustified with poor performance on the Freeport LPG export expected though at least 2018 and a delay in the CPChem project in-service due to Hurricane Harvey. He expects multiple compression to weigh on the shares.
11/14/17
11/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. General Electric (GE) downgraded to Sector Perform from Outperform at RBC Capital with analyst Deane Dray saying that he now expects the turnaround at the company to be more protracted than previously anticipated, noting the roadmap laid out by new CEO John Flannery fell short of expectations regarding the scope of the business model/portfolio changes. 2. Phillips 66 (PSX) downgraded to Underweight from Equal Weight at Barclays analyst Paul Cheng saying the company's diversified business model will likely drive underperformance in a strong margin uptrend environment for U.S. refiners. 3. Hilton (HLT) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Stephen Grambling citing the recent outperformance of the stock for the rating change, but he expects consistent double-digit earnings growth on low single-digit RevPAR. 4. PulteGroup (PHM) downgraded to Neutral from Buy at Buckingham with the firm citing recent share strength and raised its price target to $33 from $31. 5. Albemarle (ALB) downgraded to Hold from Buy at Deutsche Bank with analyst David Begleiter downgraded Albemarle (ALB) to Hold from Buy while raising his price target for the shares to $150 from $130. Following a field trip to China, Begleiter believes new lithium processing capacity is coming, which should begin to pressure prices by 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/17
LEHM
11/14/17
DOWNGRADE
Target $100
LEHM
Underweight
Phillips 66 downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Paul Cheng downgraded Phillips 66 to Underweight while raising his price target for the shares to $100 from $95. The company's diversified business model will likely drive underperformance in a strong margin uptrend environment for U.S. refiners, the analyst contends.
10/17/17
WELS
10/17/17
NO CHANGE
Target $91
WELS
Market Perform
Phillips 66 price target raised to $91 from $84 at Wells Fargo
Wells Fargo raised its price target for Phillips 66 to $91 from $84 saying a product-driven rally is on track. The analyst reiterates a Market Perform rating on the shares.
VLO Valero
$92.80

0.89 (0.97%)

11/16/17
STPT
11/16/17
DOWNGRADE
STPT
Hold
Valero downgraded to Hold from Buy at Standpoint Research
10/23/17
MACQ
10/23/17
DOWNGRADE
MACQ
Neutral
Valero downgraded to Neutral from Outperform at Macquarie
10/24/17
MACQ
10/24/17
DOWNGRADE
Target $79
MACQ
Neutral
Valero downgraded to Neutral on valuation at Macquarie
As previously reported, Macquarie downgraded Valero to Neutral from Outperform and raised its price target to $79 from $73. Coverage was transferred to analyst Jay Tobin who said Valero's superior asset base, and leverage to improving long-term crack spreads is increasingly discounted in the current prices as near-term risk to light heavy spread compression and uncertain RIN costs.
11/02/17
EVER
11/02/17
UPGRADE
EVER
Outperform
Valero upgraded to Outperform from In Line at Evercore ISI
Evercore ISI analyst Doug Terreson upgraded Valero to Outperform with a $94 price target. Terreson expects profits in Refining, Chemicals and Midstream will strengthen during 2018-2019 and does not believe consensus estimates reflect his positive outlook.

TODAY'S FREE FLY STORIES

AWK

American Water

$80.80

0.3 (0.37%)

11:51
05/22/18
05/22
11:51
05/22/18
11:51
Hot Stocks
Illinois American Water invests approx. $430,000 in Ransom drinking water system »

Illinois American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$71.78

0.4 (0.56%)

11:50
05/22/18
05/22
11:50
05/22/18
11:50
Options
Notable spreads in Nike »

Notable spreads in Nike.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

XLE

Energy Select Sector SPDR

$79.27

0.4 (0.51%)

11:46
05/22/18
05/22
11:46
05/22/18
11:46
Technical Analysis
Technical Take: Energy Select Sector SPDR hits new 52-week high »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$85.71

-3.64 (-4.07%)

11:45
05/22/18
05/22
11:45
05/22/18
11:45
Recommendations
BioMarin analyst commentary  »

BioMarin 'raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 12

    Sep

DO

Diamond Offshore

$20.60

0.71 (3.57%)

11:45
05/22/18
05/22
11:45
05/22/18
11:45
Options
Diamond Offshore call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$104.25

0.17 (0.16%)

11:41
05/22/18
05/22
11:41
05/22/18
11:41
Conference/Events
Albemarle management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 04

    Jun

  • 05

    Jun

GIS

General Mills

$42.00

0.23 (0.55%)

11:40
05/22/18
05/22
11:40
05/22/18
11:40
Conference/Events
General Mills management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Bid/Cover data reported »

52-Week Bill Auction…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Total Amount data reported »

52-Week Bill Auction…

MYND

MYnd Analytics

$2.66

-0.5 (-15.82%)

11:33
05/22/18
05/22
11:33
05/22/18
11:33
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$620.18

-45.5 (-6.84%)

11:32
05/22/18
05/22
11:32
05/22/18
11:32
Technical Analysis
Technical Take: AutoZone back near lows of the day »

After a brief bounce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TJX

TJX

$87.50

2.84 (3.35%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Earnings
TJX sees Q2 revenue approx. $9B, consensus $8.47B »

Expects wage increases to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RCII

Rent-A-Center

$10.07

-0.14 (-1.37%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Options
Notable ratio spread in Rent A Center »

Notable ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$86.77

2.11 (2.49%)

11:28
05/22/18
05/22
11:28
05/22/18
11:28
Earnings
TJX sees FY19 revenue $37.7B-$37.9B, consensus $37.87B »

Expects pretax profit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

TGT

Target

$76.39

-0.47 (-0.61%)

, AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

11:27
05/22/18
05/22
11:27
05/22/18
11:27
Earnings
On The Fly: What to watch in Target's earnings report »

Target (TGT) is scheduled…

TGT

Target

$76.39

-0.47 (-0.61%)

AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

WMT

Walmart

$84.33

-0.17 (-0.20%)

SHLD

Sears

$3.35

-0.29 (-7.97%)

JCP

J.C. Penney

$2.41

-0.1 (-3.99%)

KSS

Kohl's

$61.15

-4.32 (-6.60%)

W

Wayfair

$84.92

-0.6 (-0.70%)

TSLA

Tesla

$277.25

-7.24 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

  • 30

    May

  • 01

    Jun

  • 04

    Jun

  • 19

    Jun

11:25
05/22/18
05/22
11:25
05/22/18
11:25
Conference/Events
RBC commodity strategist to hold a luncheon meeting »

Group Luncheon Meeting,…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

, BMRN

BioMarin

$85.77

-3.58 (-4.01%)

11:21
05/22/18
05/22
11:21
05/22/18
11:21
Recommendations
Spark Therapeutics, BioMarin analyst commentary  »

Spark Therapeutics should…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

BMRN

BioMarin

$85.77

-3.58 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

ADSK

Autodesk

$138.56

1.05 (0.76%)

11:20
05/22/18
05/22
11:20
05/22/18
11:20
Options
Autodesk calls active ahead of earnings »

Autodesk calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 14

    Jun

TJX

TJX

$86.18

1.52 (1.80%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Hot Stocks
TJX 'disproportionally' attracting millennial customers »

TJX "very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/22/18
05/22
11:16
05/22/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/18
05/22
11:15
05/22/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

TJX

TJX

$86.14

1.48 (1.75%)

11:13
05/22/18
05/22
11:13
05/22/18
11:13
Recommendations
TJX analyst commentary  »

JPMorgan stays Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

CCJ

Cameco

$10.72

-0.66 (-5.80%)

11:10
05/22/18
05/22
11:10
05/22/18
11:10
Options
Call buyers in Cameco as shares see relative weakness »

Call buyers in Cameco as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.